ArticleSurgical endoscopy2025
Impact of post-RYGB gastrogastric fistula repair on metabolic and reflux outcomes.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundGastrogastric fistula (GGF) is a rare complication of Roux-en-Y gastric bypass (RYGB) associated with recurrent weight gain, worsening reflux, and Type II diabetes (T2DM) recurrence. Though surgical repair improves weight loss, the metabolic and reflux-related benefits remain ill-defined.
methodsCase series of RYGB patients with GGF who underwent laparoscopic repair via GGF takedown with partial gastrectomy without concurrent gastrojejunal anastomotic revision or bypass distalization, stratified by GLP-1 exposure. Anthropometric and metabolic parameters were abstracted pre- and post-RYGB, on GGF diagnosis, and following repair. Cumulative fistula size was estimated from preoperative endoscopy. Outcomes included total weight loss (TWL%), HbA1c, changes in antidiabetic therapy, reflux outcomes, and complications.
resultsThirty-one patients, 28 (90.3%) female with mean (SD) age of 52.7 (8.6), underwent GGF repair between 2014 and 2024. Index RYGB was performed 16.8 (5.8) years earlier with 27 (87.1%) in open fashion. Median [IQR] cumulative fistula size was 15 [11.3, 20] mm. Fourteen (45.2%) patients received pre- and/or postoperative GLP-1 agonists and 14 (45.2%) underwent previous unsuccessful attempts at endoscopic closure. On diagnosis, 24 (77.4%) patients had symptomatic reflux, 6 (19.4%) prediabetes, and 4 (12.9%) T2DM. Concurrent hiatal hernia repair was performed in 5 (15.6%) cases. One year following repair, mean TWL% was - 14.2% (12.3) relative to repair, 83.3% had clinical resolution of reflux, and those with prediabetes or diabetes exhibited mean [95%CI] HbA1c reduction of - 0.64 [- 1.0, - 0.28].
conclusionLaparoscopic GGF repair following RYGB is associated with significant weight loss, resolution of reflux symptoms, and metabolic improvements, even following trials of medical or endoscopic therapy. Our study highlights the potential metabolic impact of GGF and supports the evaluation and repair of GGF in appropriate candidates with recurrent weight gain, reflux, or diabetes after RYGB.
Indexed as
Identifiers
40634724What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.